ロード中...
AB027. S6-1. Biomarkers in cholangiocarcinoma
Surgery is the mainstay of early-stage cholangiocarcinoma (CCA); chemotherapy and experimental therapies remain the therapeutic cornerstone in unresectable and metastatic CCA. However, there is no biomarker with clinical utility to predict post-operative tumor recurrence and to select patients most...
保存先:
| 出版年: | Hepatobiliary Surg Nutr |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AME Publishing Company
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6421228/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2019.AB027 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|